Novel Coronavirus (COVID-19)

Pancreatic cancer is not just one disease, but that’s the way it is currently treated. New work from Tannishtha Reya’s lab could help pave the way for a change.

Researchers have found a protein to block the growth of cancer stem-like cells as a possible treatment for pancreatic cancer.

Often called “dark matter”, it could alter the way cancer is detected and treated, research from The Institute of Cancer Research suggests.

A number of trials are exploring immune-oncology (IO) therapies in combination with VEGF antibodies, tyrosine kinase inhibitors (TKIs), and other IO agents as potential new strategies for patients with hepatocellular carcinoma. A presentation by Richard S. Finn, MD, during the American Association for Cancer Research Special Conference, focused on phase 3 combination studies in that setting.

University of Arizona researchers have been working for decades to develop a drug that so specifically targets a deadly kind of breast cancer that there are little to no toxic side effects.

More metastatic breast cancer patients may be eligible to receive a treatment recently approved by the U.S. Food and Drug Administration (FDA) for a newly defined category called “HER2-low” metastatic breast cancer. October, 2022

Researchers have turned to drug delivery nanoparticles to maximize the anti-cancer STING of a molecule, pointing to a possible way to unlock the potential of a pathway that has caught the eye of the industry.

Scientists have discovered DNA-damaging molecules made by gut bacteria that may help explain why people with inflammatory bowel disease (IBD) have higher rates of colorectal cancer than those without the condition.

Imjudo plus Imfinzi improved overall survival compared with standard targeted therapy for hepatocellular carcinoma.

An estimated 2.3 million womenTrusted Source around the world received a diagnosis of breast cancer in 2020. That same year, about 685,000 women globally died from the disease.